Allez Health

Executive Summary

Allez Health is a San Diego-based medical device company founded in 2020, aiming to redefine metabolic monitoring through continuous biosensors. Its initial focus is on continuous glucose monitoring (CGM) and continuous lactate sensing, targeting both diabetic and athletic populations. The company is led by a seasoned team with deep expertise in biosensor technology, including key inventors from the Dexcom G4 CGM system. This pedigree positions Allez Health to potentially disrupt the CGM market, which is dominated by Dexcom and Abbott, by offering uncompromising sensor accuracy and user experience. Additionally, continuous lactate sensing represents a novel application with potential in sports performance and critical care monitoring, opening new revenue streams beyond traditional diabetes management.

Upcoming Catalysts (preview)

• Q1 2027FDA submission of next-generation CGM system40% success
• Q3 2026Series B funding round70% success
• Q2 2027Strategic partnership with a diabetes care company30% success